Stay updated on PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib
Sign up to get notified when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.

Latest updates to the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page
- Check5 days agoChange DetectedLocations section updated to include Ilhe de France. The Ilhe de France Locations entry was removed, and the page revision updated to v3.3.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page update shows Revision: v3.3.2, replacing v3.3.1. This is a system-level UI update and does not affect study details or user-facing content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedPublication added: Callens et al., 2023, Oncogene is now cited in the Publications section. The related topics list was expanded to include MedlinePlus Genetics, and the page revision is labeled v3.3.1.SummaryDifference0.2%

- Check41 days agoChange DetectedRemoved the government funding lapse notice from the page; core trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedThe MedlinePlus related topics section no longer displays the 'Ovarian cancer' and 'MedlinePlus Genetics' links on the PAOLA-1 study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedScreenshots indicate only minor UI/layout adjustments on the study details page; essential content such as trial design, eligibility criteria, and outcomes appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib
Enter your email address, and we'll notify you when there's something new on the PAOLA-1 Clinical Trial: Platine, Avastin, OLAparib page.